Scintigraphy with 67Ga citrate in the study of lymphomas;La gammagrafía con citrato de 67Ga en el estudio de los linfomas

Revista Espanola de Medicina Nuclear

Volumn 21, Issue 2, 2002, Pages 85-87

  Ricart, Y ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67; CITRIC ACID; DIAGNOSTIC AGENT; FLUORINE; GALLIUM; GALLIUM CITRATE; RADIOPHARMACEUTICAL AGENT;

CANCER SCINTISCANNING; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; HODGKIN DISEASE; HUMAN; LYMPHOMA; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CANCER STAGING; FOLLOW UP; MINIMAL RESIDUAL DISEASE; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

CITRATES; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GALLIUM; GALLIUM RADIOISOTOPES; HUMANS; LYMPHOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036546601     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/s0212-6982(02)72040-5     Document Type: Editorial

References (18)

1. 67Ga citrate. J Nucl Med 1969;10:103-5.
2. Anderson KC, Leonard RC, Canellos GP. High dose gallium imaging in lymphoma. Am J Med 1983;75:327-31.
3. 67Ga SPECT. Radiology 1987;164:111-4.
4. 67Ga in tumors. Semin Nucl Med 1978;8:193-203.
5. 67gallium citrate and (2-3H) doxyglucose in the tumor model, following chemotherapy and radiotherapy. Eur J Nucl Med 1990;16:755-71.
6. 67Ga scintography after one cycle of chemotherapy. Radiology 1999;210:487-91.
7. Janicek M, Kaplan W, Neuberg D, et al. Early restaging gallium scans predict outcome on poor prognosis patients with agressive non Hodgkin's lymphoma trated with high-dose CHOP chemotherapy. J Clin Oncol 1997;15:1631-7.
8. 67Ga scintigraphy. Nuclear Medicine Annual 1991:211-20.
9. 67Ga scintigraphy. J Nucl Med 1993;12:2101-4.
10. 67Ga scintigraphy in low grade non Hodgkin's lymphoma. J Clin Oncol 1996;14:1936-42.
11. Weeks JC, Yeap BY, Canellos GP, et al. Value of follow procedures in patients with large-cell lymphoma who achieve a complete remision. J Clin Onc 1991;9:1196-203.
12. Salloum E, Schwab Brandt D, Caride VJ, et al. Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients. J Clin Oncol 1997;15:518-27.
13. 67Ga imaging a predictor of residual tumorviability and clinical outcome in patients with diffuse large-cell-lymphoma. J Clin Oncol 1990;8:1966-70.
14. Bogart JA, Chung CT, Mariados NF, et al. Thu value of gallium imaging after therapy gor Hodgkin's disease. Cancer 1998;82:754-9.
15. Buchmann I, Reinhardt M, Elsner K, et al. 2-(Fluorine-18) Fluoro-2-deoxy-D-glucosse positron emission tomography in the detection and staging of malignant lymphoma. Cancer 2001;91:899-99.
16. Stumpe KDM, Urbinelli M, Steinert HC, et al. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. Eur J Nucl Med 1998;25:721-8.
17. De Wit M, Bumann D, Beyer W, et al. Whole body positron emission tomography (PET) for diagnosis of residual mass in patints with lymphoma. Ann Oncol 1997;8:57-60.
18. 18F-fluorodeoxyglucose for post-treatement evaluation in Hodhkin's disease and non Hodgkin's lymphma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood 199;94:4464-71.